RobinHood Telehealth

Discover the Power of GLP-1 for Weight and Blood Sugar Control

Clinically proven to help regulate appetite, stabilize blood sugar, and support long-term wellness. 

What is GLP-1?

Understanding GLP-1: A Natural Hormone with Powerful Health Benefits

GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces in response to food. It plays a key role in regulating blood sugar, managing appetite, and improving metabolic function. Medical science has harnessed GLP-1’s power in treatments that help people manage weight and type 2 diabetes more effectively. 

Key Points: 

How GLP-1 Contributes to a Healthier Body

Reduces Cravings and Hunger

Promotes fullness and satiety

Stabilizes Blood Sugar Levels

Especially after meals

Encourages Sustainable Weight Loss

Supports metabolic health

Medications that Leverage GLP-1 Science

Semaglutide (Ozempic®, Wegovy®)
Liraglutide (Saxenda®, Victoza®)
Tirzepatide (Mounjaro®, Zepbound®)

FAQs

What does GLP-1 do in the body?

It helps your body manage blood sugar and reduces appetite, playing a key role in weight and metabolic regulation. 

Yes, GLP-1-related therapies are also approved for weight management in people without diabetes.

Certain foods, exercise, and sleep hygiene may support your body’s natural GLP-1 production.

Our goal is to help people achieve their weight loss and wellness goals, no matter their age or gender, or how much weight they want to lose. We’re dedicated to giving you the tools and guidance you need to reach and maintain a healthy weight and lifestyle.

We understand that everyone’s body is different, which is why we have built in a fitness and nutrition DNA test into our program. This will allow for a tailored program based on your body’s genetic disposition. 

While all medicines can result in potential side effects, it can be risky for patients to use unapproved versions (such as compounded “semaglutide”) because they do not undergo FDA review. Without the FDA’s review, the safety, quality, and effectiveness of what is being marketed and sold as alleged “semaglutide” has not been established. Because of this, the FDA alerted the public that “compounded drugs pose a higher risk to patients than FDA-approved drugs.”

No. There are currently no FDA-approved generic versions of medicines containing semaglutide available. 

Semaglutide was discovered in the early 2000s by researchers at Novo Nordisk. Semaglutide works by mimicking a hormone naturally found in our bodies, GLP-1 (short for “glucagon-like peptide-1”).

It is a peptide (a short chain of amino acids) that is the main ingredient (also known as “active pharmaceutical ingredient”) in three different FDA-approved prescription medicines for patients with type 2 diabetes or obesity, with or without established cardiovascular disease.